Compounder Recalls All Products After Mold Found

Law360, New York (March 18, 2013, 7:07 PM EDT) -- The U.S. Food and Drug Administration announced Monday that a New Jersey compounding pharmacy had recalled all of its products after mold was discovered in several bags of an intravenous solution, in an incident that could fuel the FDA's push for more authority to regulate compounders.

On Sunday, Med Prep Consulting Inc. voluntarily recalled all lots of all products compounded at its pharmacy, after employees at a Connecticut hospital noticed visible particles in five bags of magnesium sulfate solution. The visible particles were found to be...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.